- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06282185
SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy (Superman)
The goal of this single blind placebo-controlled intervention study is to examine the impact of a supervised training program on disease-related quality of life and physical fitness in patient with advanced prostate cancer compared to usual care. The main question[s] it aims to answer are:
- What is the impact of exercise on quality of life
- What is the impact of exercise on physical fitness
Participants will have an individual training program with supervised training by physiotherapists.
Researchers will compare with usual care to see if advice about exercise has significant less effect than an supervised training program.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: stijn Elbers, MD
- Phone Number: (+31)243657657
- Email: s.elbers@cwz.nl
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Signed informed consent
- Age > 18 years old
- Able to read and complete questionnaires in Dutch
- Proven histologically and /or radiologically metastatic prostate cancer (TxNxM1)
Exclusion Criteria:
- Other cancers
- Clinicians' judgement
- Age >80 years old or not able to walk 400m
- Structural exercise (moderate-intensity exercise more than 150 minutes a week) during the past 3 months
- Musculoskeletal, cardiovascular, or neurological disorders that could inhibit them from exercising
- Spinal cord compression, history of pathological fractures
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: intervention
supervised training program for twelve weeks + usual care + advice about exercise
|
supervised training program for twelve weeks + usual care + advice about exercise
|
No Intervention: usual care
usual care + advice about exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change of quality of life assessed with EPIC26 (0-100 points)
Time Frame: 6 months
|
To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care.
The following questionnaire is used: Expanded Prostate Cancer Index Composite (EPIC26).
With higher scores representing better disease-related quality of life.
|
6 months
|
change of quality of life assessed with EPIC26 (0-100 points)
Time Frame: 3 months
|
To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care.
The following questionnaire is used: Expanded Prostate Cancer Index Composite (EPIC26).
With higher scores representing better disease-related quality of life.
|
3 months
|
change of quality of life assessed with EORTC QLQ-C30 (0-100 points per scale)
Time Frame: 6 months
|
To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care.
The following questionnaires are used: European Organization for Research and Treatment for Cancer Quality of Life Questionnaire (EORTC QLQ-C30).
A higher score represents a higher response level.
So a higher score for the functional scale represents a higher level of physical functioning but a higher score for the symptoms scale represents a higher level of symptoms.
|
6 months
|
change of quality of life assessed with EORTC QLQ-C30 (0-100 points per scale)
Time Frame: 3 months
|
To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care.
The following questionnaires are used: European Organization for Research and Treatment for Cancer Quality of Life Questionnaire (EORTC QLQ-C30).
A higher score represents a higher response level.
So a higher score for the functional scale represents a higher level of physical functioning but a higher score for the symptoms scale represents a higher level of symptoms.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change of physical fitness in maximum uptake of oxygen in ml/kg/min
Time Frame: 6 months
|
Assessment of the effectiveness of a supervised training program on cardiopulmonary fitness in patients with metastatic prostate cancer compared to usual care.
|
6 months
|
change of physical fitness in maximum uptake of oxygen in ml/kg/min
Time Frame: 3 months
|
Assessment of the effectiveness of a supervised training program on cardiopulmonary fitness and body composition in patients with metastatic prostate cancer compared to usual care.
|
3 months
|
change of physical fitness in fat percentage
Time Frame: 3 months
|
change in body composition in patients with metastatic prostate cancer compared to usual care.
|
3 months
|
change of physical fitness in fat percentage
Time Frame: 6 months
|
change in body composition in patients with metastatic prostate cancer compared to usual care.
|
6 months
|
change of fitness assessed with IPAQ-sh (categories (1-3) and continues (MET-minutes))
Time Frame: 3 months
|
To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care.
The following questionnaires are used: Short Hebrew International Physical Activity Questionnaire (IPAQ-sh).
Both categorical and continuous indicators of physical activity will be used from the IPAQ short form.
There are three categories:1.
inactive, 2. minimally active, 3. HEPA active (health enhancing physical activity; a high active category).
The continuous score is reported in median MET-minutes (metabolic equivalent of task-minutes).
For categorical and continuous score is a higher score equivalent of higher physical functioning.
|
3 months
|
change of fitness assessed with IPAQ-sh (categories (1-3) and continues (MET-minutes))
Time Frame: 6 months
|
To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care.
The following questionnaires are used: Short Hebrew International Physical Activity Questionnaire (IPAQ-sh).
Both categorical and continuous indicators of physical activity will be used from the IPAQ short form.
There are three categories:1.
inactive, 2. minimally active, 3. HEPA active (health enhancing physical activity; a high active category).
The continuous score is reported in median MET-minutes (metabolic equivalent of task-minutes).
For categorical and continuous score is a higher score equivalent of higher physical functioning.
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jean-Paul van Basten, Dr. MD, Canisius Wilhelmina Ziekenhuis (CWZ)
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CanisiusWH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostatic Neoplasms
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaRecruitingCastration Resistant Prostatic CancerAustralia
-
Technische Universität DresdenRecruitingOligometastatic Disease | Prostatic Cancer, Castration-ResistantGermany
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer
-
Institut Claudius RegaudWithdrawnProstatic Cancer, Castration-ResistantFrance
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
University Hospital, GrenobleTerminatedCastration-resistant Prostate CancerFrance
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer CenterActive, not recruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Cancer Recurrent | Prostatic Cancer MetastaticUnited States
-
Rio de Janeiro State UniversityCompletedProstatic Cancer | Prostatic NeoplasmBrazil
Clinical Trials on Physiotherapy
-
Hacettepe UniversityCompleted
-
Manchester Metropolitan UniversityCompleted
-
Rigshospitalet, DenmarkThe Association of Danish Physiotherapists Research Fund, Denmark; The Jubilee...CompletedTrismus | Oropharyngeal Cancer | Oral Cavity Carcinoma | Adverse Effect of Radiation TherapyDenmark
-
University of OviedoCompletedParkinson Disease
-
Isra UniversityCompleted
-
Clinique du Sport, Bordeaux MérignacNot yet recruiting
-
University of Nove de JulhoUniversidade Federal do CearaRecruitingEdema | ParesthesiaBrazil
-
Ambreen ChohanBlackpool Victoria HospitalCompletedKnee Osteoarthritis | Exercise | Rehabilitation | Physiotherapy | InterventionUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceTerminated